The latest update is out from Almirall ( (ES:ALM) ).
Almirall has announced a transition in its Chief Financial Officer position, with Jon U. Garay Alonso set to take over in August 2025. This change is part of a planned succession as current CFO Mike McClellan steps down to pursue other career opportunities. Jon brings over 25 years of experience in finance across various sectors, including pharmaceuticals, which positions him well to contribute to Almirall’s strategic goals.
More about Almirall
Almirall is a pharmaceutical company that focuses on developing and commercializing medicines, primarily in the dermatology sector. It aims to provide innovative medical solutions to improve patients’ quality of life.
YTD Price Performance: 23.09%
Average Trading Volume: 3,392
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €2.09B
Learn more about ALM stock on TipRanks’ Stock Analysis page.